![](/img/cover-not-exists.png)
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy
Shiseki, Masayuki, Yoshida, Chikashi, Takezako, Naoki, Ohwada, Akira, Kumagai, Takashi, Nishiwaki, Kaichi, Horikoshi, Akira, Fukuda, Tetsuya, Takano, Hina, Kouzai, Yasuji, Tanaka, Junji, Morita, SatosLanguage:
english
Journal:
International Journal of Clinical Oncology
DOI:
10.1007/s10147-017-1141-y
Date:
May, 2017
File:
PDF, 696 KB
english, 2017